Pedskin Research dermatology innovations

Treatments for Atopic Dermatitis in Children

Is your child struggling with dry, itchy, or inflamed skin?

A new clinical trial is now enrolling children aged 6 to 11 with moderate to severe Atopic Dermatitis.

Clinical Trials for Atopic Dermatitis

At Pediatric Skin Research (PedSkin), we specialize exclusively in conducting clinical trials to advance new treatment options for children with skin conditions like Atopic Dermatitis (AD).
Our mission is to contribute to the development of safer, more effective therapies through carefully designed and closely monitored research studies.

Why Enroll in a Clinical Trial?

  • Early access to promising new treatments before they are FDA-approved.
  • No cost for participation, and compensation for travel-related expenses.
  • Expert care from board-certified pediatric dermatologists.
  • Contribute to future treatments that could help other children with AD.

Eligibility for Clinical Trials

Each study has specific age and symptom requirements. In general, participants must:

  • Have a confirmed diagnosis of moderate to severe AD.
  • Have at least 10% of their body covered by AD (for systemic treatment trials).
  • Meet weight requirements (e.g., Amlitelimab requires ≥25 kg).
  • Be willing to follow study protocols (regular clinic visits, follow-up assessments).

Current Ongoing Trials at Pediatric Skin Research

We currently have four active clinical trials for pediatric patients with mild to severe AD:

Clinical Trial Age Group Medication Type of Treatment
Tralokinumab 2-11 years IL-13 antibody Subcutaneous injection
Upadacitinib vs Dupilumab 6-11 years JAK1 inhibitor vs IL-4/IL-13 Oral vs Injection
Roflumilast Cream 3-24 months PDE4 inhibitor Topical cream
Nemolizumab 12 years+ IL-31 inhibitor Subcutaneous injection (under investigation)

Meet Our Medical Director

Mercedes E. Gonzalez M.D.
Mercedes E. Gonzalez M.D.
Pedskin Research treatment for skin conditions

Dr. Mercedes E. Gonzalez is a board-certified pediatric dermatologist. After graduating from Emory University, she earned her degree at Rutgers–New Jersey Medical School in 2004. Always drawn to working with children, she accepted the prestigious pediatrics program at the Morgan Stanley Children’s Hospital of New York–Columbia University where she solidified her interest in treating skin disorders. She then completed a dermatology residency followed by a clinical fellowship in pediatric dermatology at the top-ranked New York University (NYU) Department of Dermatology.

Her gentle, child-friendly bedside manner, combined with her broad knowledge of childhood skin diseases and their treatments, make her the preferred pediatric dermatologist in Miami. In addition to practicing medicine, Dr. Gonzalez currently serves as a clinical assistant professor at The FIU Herbert Wertheim School of Medicine and The Phillip Frost Department of Dermatology at Miller School of Medicine.

Dr. Gonzalez serves as the principal investigator on numerous clinical trials and has a special interest in severe skin diseases in children. She lectures regularly at dermatology conferences and to medical students and residents and is the co-editor of 3 dermatology textbooks, including the recently published 2nd edition of Goodheart’s Same Site Differential Diagnosis, and has published over 50 journal articles.

  • Board-certified pediatric dermatologist.

  • Graduated from Emory University.

  • Earned her degree at rutgers–New Jersey Medical School in 2004.

  • Dr. Gonzalez accepted the prestigious pediatrics program at the Morgan Stanley Children’s Hospital of New York–Columbia University where she solidified her interest in treating skin disorders.

  • She then completed a dermatology residency at the top-ranked New York School of Medicine, followed by a clinical fellowship in pediatric dermatology.

Pedskin Research treatment for skin conditions
Pedskin Research pediatric dermatology

Request An Appointment

To request an appointment, please fill out the contact form below. Our team will get back to you as soon as possible to confirm your appointment and answer any questions you may have. We look forward to assisting you.

Atopic Dermatitis Treatment
Opt-In

Join Our Free Webinar
New Treatments for Atopic Dermatitis in Children

📅Date to Be Determined

ABOUT THIS WEBINAR

Explore cutting-edge therapies in pediatric dermatology with our upcoming webinar on novel treatments for atopic dermatitis in children and adolescents. This session highlights ongoing clinical trials evaluating advanced topical and systemic therapies—including biologics and JAK inhibitors—for moderate to severe eczema in patients aged 6 months to 17 years.

Join us to learn more about trial designs, safety protocols, and breakthrough findings shaping the future of atopic dermatitis care.

Learn more about this trial and see if your child is a candidate.

Pedskin Research pediatric dermatology

FILL OUT THE FORM BELOW
AND JOIN OUR ATOPIC DERMATITIS WEBINAR

Atopic Dermatitis Webinar
Opt-In

Understanding Atopic Dermatitis (Eczema)

Atopic Dermatitis (AD) is a chronic skin condition that causes recurrent itchy, inflamed plaques on the skin. It is not life-threatening, but it can significantly impact a child’s quality of life, leading to sleep disturbances, discomfort, and increased risk of infections.

AD is caused by a combination of genetic, immune, and environmental factors that result in skin barrier dysfunction and excessive inflammation. Children with AD often experience flare-ups triggered by allergens, irritants, weather changes, or stress.

Pedskin Research clinical dermatology studies

Prevalence and Impact

  • AD affects 13-25% of children and 2-10% of adults.
  • Studies show a higher prevalence in Black children (19.3%) compared to White children (16.1%).
  • Children with severe AD may experience greater social and emotional distress due to itching, visible skin changes, and sleep disruption.

When to Consider Systemic Medications

Children with moderate to severe AD may need systemic (whole-body) treatments when:

  • Topical treatments no longer work and flares continue.
  • Itching and skin discomfort interfere with sleep, school, or daily activities.
  • The treatment regimen is burdensome or ineffective.
  • The child has other allergic conditions (asthma, food allergies).
Pedskin Research child skin care

Frequently Asked Questions

Atopic dermatitis, or eczema, is a chronic skin condition that causes dryness, redness, and itching. It is common in children and results in itchy flare ups periodically.

It is caused by a combination of genetic, immunologic and environmental factors. Children with a family history of allergies, asthma, or eczema are more likely to develop it.

No, eczema is not contagious. It cannot be spread from person to person.

Moisturizing regularly, using fragrance-free skincare products, avoiding irritants, and following a treatment plan prescribed by a doctor can help manage symptoms.

Some children may also have food allergies. Occasionally foods that touch the eczema prone areas of skin can trigger a flare of the child’s eczema. If you suspect food allergies, consult a doctor for testing.

We offer treatment plans tailored to each child’s needs including medical-grade moisturizers, prescription creams, and systemic medications given via oral route or injection. We thoroughly discuss risks and benefits of all available treatment options with families and determine the best course for each individual child.

Yes, stress can trigger flare-ups. Helping your child manage stress through relaxation techniques may help reduce symptoms.

Soft, breathable fabrics like cotton are best. Avoid wool, synthetic materials, and rough fabrics that can irritate the skin.

Yes! Ensure their skin is protected with sunscreen, soft clothing, and moisturization before and after outdoor activities.

Many children see improvements as they get older, but some may continue to have eczema into adulthood.